ortho-Nitroanisole is a nitroaromatic organic compound with the molecular formula CH3OC6H4NO2. It consists of a methoxy group (-OCH3) and a nitro group (-NO2) substituted on a benzene ring in the ortho- position[1]. Three isomers of nitroanisole exist, but the ortho-isomer is the most commercially important.
Typically the compound is a colourless - pale yellow liquid[1] and is primarily used as a precursor to o-anisdine, an important compound in azo-dye manufacturing[2][3]. o-Nitroanisole has been commercially produced as early as the beginning of the 20th century.[4]
Beyond synthetic applications, o-nitroanisole has been subject to toxicological and environmental studies[5][6], particularly concerning occupational exposure and potential health effects associated with nitroaromatic compounds.[5][6]
History
Precise documentation for the first synthesis of o-nitroanisole is not readily available but early industrial relevance is clearly established pre-WWII.[4] During the early 1900s it was identified as a chemical intermediate in dye and chemical manufacturing. A 1936 US patent describes improved production methods explicitly stating ‘o-nitro-anisole has been known widely and used for a number of years.[4] The patents focuses indicates large scale synthesis challenges were already important commercially at the time.
Its significance is primarliy linked to the product formed after reduction of the nitro group, forming o-anisidine. This compound is an important intermediate for azo dye synthesis. The growth of the synthetic dye industry in early-mid 20th century drove demand for o-nitroanisole.[6] From 1970s onwards, toxicological and regulatory studies documented properties, exposure and potential health effects attributable to o-nitroanisole.[7]
Synthesis
o-Nitroanisole is classically prepared by electrophilic aromatic nitration of anisole using nitric acid in the presence of sulphuric acid[8]. The methoxy substituent activating effects are ortho/para directing, which forms a mixture of regioisomers[9] that require further efforts to isolate o-nitroanisole.
Modern industrial production commonly synthesises o-nitroanisole by nucleophilic aromatic substitution of o-nitrochlorobenzene with methanolic sodium hydroxide or sodium methoxide[1][2][5][6]. The nitro group activates the ring to displace the chloro substituent[9]. This approach increases selectivity towards o-nitroanisole and is often associated with yields around 90%.[1]
NaOCH3 + ClC6H4NO2 → CH3OC6H4NO2 + NaCl
Exposure
The main environmental exposure is attributed to waste streams of pharmaceuticals and dye facilities.[10][11] Historically, o-nitroanisole has been found as a water contaminant in Japan, China, Germany and the Netherlands where it absorbs into sediment and solids. Traces have been found in drinking water but concentrations have not been measured and currently there is no proof of bioaccumulation in aquatic organisms. Vapours of o-nitroanisole have been identified but naturally degrade, with a half life of 109 hours.[11]
Exposure to the general population occurs with contact to environmental contaminants, occupational exposure can occur during azo-dye manufacturing through skin contact or inhalation.[10]
Metabolism
o-Nitroanisole itself is not toxic in the body [12], but undergoes oxidative and reductive biotransformations. This generates reactive intermediates responsible for the genotoxic and carcinogenic effects.[13][14]The primary route of metabolism is oxidation, mediated by CYP 450, to form 2-nitrophenol. A non-reactive metabolite which is readily excreted from the body.[13][14]
The other route of metabolism is reduction of the nitro group (-NO2) to an amine (-NH2), mediated by hepatic reductase and xanthine oxidase, to form o-anisidine.[12][15][16] This metabolite undergoes further bioactivation to hydroxylamine derivatives. The oxidation of o-anisidine and hydroxylamine derivatives by CYP enzymes generates N-(2-methoxyphenyl)hydroxylamine that rearrange to nitrenium ions.[10][15][17]
Nitrenium ions are a highly reactive species that preferentially binds to nucleophilic sites on DNA. In vivo rodent studies found evidence for tissue-specific metabolism, with DNA adducts primarily detected in the urinary bladder, liver, and spleen.[16][17] The data is consistent with the distribution of the metabolising enzymes in these organs.[17][18]
1234Program, National Toxicology (2021-12-21), "o-Nitroanisole", 15th Report on Carcinogens [Internet], National Toxicology Program, retrieved 2026-03-10
123Humans, IARC Working Group on the Identification of Carcinogenic Hazards to (2021), "ortho-Nitroanisole", Some Aromatic Amines and related Compounds, International Agency for Research on Cancer, retrieved 2026-03-10
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.
